Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Van Bambeke
Phage-Derived Depolymerase-Functionalized Coatings Prevent Staphylococcal Biofilm Formation
Biofilm-associated infections caused by Staphylococci remain a major challenge in the context of biomedical implants due to their tolerance to antibiotics and resistance to host defenses. Here, we report the identification of a novel phage-derived depolymerase (DPO2) targeting staphylococcal biofilms and its integration into hyaluronic acid-based layer-by-layer (LbL) coatings.
Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections
The spread of ESBL-producing Enterobacteriaceae has led to increased carbapenem usage and a subsequent rise in carbapenem-resistant Gram-negative pathogens.1,2 Temocillin is a penicillin antibiotic with stability against most β-lactamases, including most ESBL types and AmpC,3–5 and thus has carbapenem-sparing potential.
Pharmacokinetics and pharmacological target attainment of standard temocillin dosing in non-critically ill patients with complicated urinary tract infections
Temocillin, a carbapenem-sparing β-lactam antibiotic, is commonly used at the standard 4 g/day dosage for treating complicated urinary tract infections (cUTIs). However, pharmacokinetic/pharmacodynamic (PK/PD) data supporting this regimen is limited. This study evaluated the plasma pharmacokinetics (PK) and PTA of temocillin in non-critically ill cUTI patients with varying degrees of renal insufficiency (RI).
Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis
Cerebral ventriculitis might be caused by Gram-negative bacteria, including ESBL producers. Temocillin may be a useful treatment option in this scenario; however, no consistent data are available regarding its penetration into the CSF. To describe the population pharmacokinetics of temocillin in plasma and CSF and to determine the probability for different simulated dosing regimens to achieve pharmacokinetic/pharmacodynamic (PK/PD) targets in the CSF.
The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa
Pharmacology Gang Wang, Jean-Michel Brunel, Jean-Michel Bolla, Françoise Van Bambeke DOI: 10.1128/AAC.02028-20 ABSTRACT Active efflux confers intrinsic resistance to multiple antibiotics in Pseudomonas aeruginosa, including old disused molecules. Beside resistance, intracellular survival is another reason for failure to eradicate bacteria with antibiotics.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Van
Contact Van, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack